These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 1532962

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. An integrated approach to treatment of obsessive compulsive disorder.
    Greist JH.
    J Clin Psychiatry; 1992 Apr; 53 Suppl():38-41. PubMed ID: 1532963
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Valproate pretreatment for the difficult-to-treat patient with OCD.
    Deltito JA.
    J Clin Psychiatry; 1994 Nov; 55(11):500. PubMed ID: 7989288
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacologic management of obsessive-compulsive disorder.
    Jackson CW, Morton WA, Lydiard RB.
    South Med J; 1994 Mar; 87(3):310-21. PubMed ID: 8134850
    [Abstract] [Full Text] [Related]

  • 6. Issues in the monopharmacotherapy and polypharmacotherapy of obsessive-compulsive disorder.
    Laird LK.
    Psychopharmacol Bull; 1996 Mar; 32(4):569-78. PubMed ID: 8993077
    [Abstract] [Full Text] [Related]

  • 7. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
    Jenike MA, Hyman S, Baer L, Holland A, Minichiello WE, Buttolph L, Summergrad P, Seymour R, Ricciardi J.
    Am J Psychiatry; 1990 Sep; 147(9):1209-15. PubMed ID: 2143637
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    Piccinelli M, Pini S, Bellantuono C, Wilkinson G.
    Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serotonin reuptake inhibitors are the treatment of choice in obsessive compulsive disorder.
    Fineberg NA, Bullock T, Montgomery DB, Montgomery SA.
    Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():43-7. PubMed ID: 1517558
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Obsessive compulsive disorder, depression, and fluoxetine.
    Hollander E, Mullen L, DeCaria CM, Skodol A, Schneier FR, Liebowitz MR, Klein DF.
    J Clin Psychiatry; 1991 Oct; 52(10):418-22. PubMed ID: 1938978
    [Abstract] [Full Text] [Related]

  • 17. The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies.
    Barr LC, Goodman WK, Price LH, McDougle CJ, Charney DS.
    J Clin Psychiatry; 1992 Apr; 53 Suppl():17-28. PubMed ID: 1532961
    [Abstract] [Full Text] [Related]

  • 18. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH.
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [Abstract] [Full Text] [Related]

  • 19. Treating the anxiety: therapeutic options in obsessive compulsive disorder.
    Greist JH.
    J Clin Psychiatry; 1990 Nov; 51 Suppl():29-34. PubMed ID: 2146255
    [Abstract] [Full Text] [Related]

  • 20. Management of treatment-refractory obsessive compulsive disorder patients.
    Dominguez RA, Mestre SM.
    J Clin Psychiatry; 1994 Oct; 55 Suppl():86-92. PubMed ID: 7961537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.